Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for AstraZeneca’s Evusheld (tixagevimab [...]
Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain [...]
Scott Newsome, DO, leads a panel discussion with thought leaders on the implications of findings from a recently published longitudinal [...]
In this program, people living with or affected by MS will have the opportunity to network with one another and to learn from leading MS [...]
TG Therapeutics has applied to the U.S. Food and Drug Administration (FDA) for approval of ublituximab, the company’s investigational [...]
NeurologyLive® Announces the Inaugural Giants of Multiple Sclerosis™ Program The first annual award program will honor [...]
The CMSC and IOMSN are proud to announce the following: Dr. Howard L. Weiner has just written a new book on brain diseases called The [...]
Consortium of Multiple Sclerosis Centers (CMSC) and Atara Biotherapeutics on Thursday - June 10, 2021 at 7:00 PM - 8:00 PM ETÂ on an [...]
These consensus guidelines are significant not only for their key updates to clinical practice but for their representation of a more [...]
Prof Mike P Wattjes, MD, Prof Olga Ciccarelli, MD, Daniel S Reich, MD, Prof Brenda Banwell, MD, Prof Nicola de Stefano, MD, Prof Christian [...]